BerGenBio ASA - Merged with Oncoinvent ASA Employee Directory

Biotechnology ResearchVestland, Norway2-10 Employees

On 29 October 2025, BerGenBio ASA completed its merger with Oncoinvent ASA. The combined company now operates under the name Oncoinvent ASA.
Oncoinvent ASA is alone in developing cancer treatment using alpha radiation for patients with cancer in the abdominal cavity – a condition with very few treatment options and a high rate of recurrence. Preliminary studies show positive research findings. The company has begun recruitment for phase 2 studies, both in Norway and internationally.
For more information about the new company, please visit Oncoinvent ASA: https://www.linkedin.com/company/oncoinvent-as/

BerGenBio’s LinkedIn page will be maintained as a historical archive. 
BerGenBio was a clinical-stage biopharmaceutical company focused on developing a pipeline of first-in-class selective AXL kinase inhibitors to treat multiple aggressive cancers.

Find BerGenBio ASA - Merged with Oncoinvent ASA employees' phone numbers or email addresses

BerGenBio ASA - Merged with Oncoinvent ASA Global Highlights

Location
Employees

Europe
13

Minus sign iconPlus sign icon
  • Norway
    8
  • United Kingdom Of Great Britain And Northern Ireland
    3
  • Netherlands
    1
  • Sweden
    1

BerGenBio ASA - Merged with Oncoinvent ASA's Leadership

  • Stylized image of a person
    O. H.
    Chief Executive Officer
    Phone icon
  • Stylized image of a person
    R. S.
    Cfo
    Phone icon
  • Stylized image of a person
    D. M.
    Chief People Officer
    Phone icon
  • Stylized image of a person
    T. S.
    Full Time Senior Researcher, Vp Of Contract Services
    Phone icon
  • Stylized image of a person
    K. W.
    Associate Director, Global Regulatory Affairs
    Phone icon
  • Stylized image of a person
    O. S.
    Director Of Financial Controlling And Business Support
    Phone icon
  • Stylized image of a person
    D. M.
    Director Of Biomarkers And Research
    Phone icon
  • Stylized image of a person
    C. B. D.
    Finance Director
    Phone icon

BerGenBio ASA - Merged with Oncoinvent ASA Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Business
  • Consultant
  • Engineering
  • Information Technology
  • Other
  • Analytics
  • Finance
  • Program & Project Management
  • Operations
  • Biotechnology
  • Entrepreneurship
  • Legal

Contact profiles from BerGenBio ASA - Merged with Oncoinvent ASA

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    O. H.
    Chief Executive Officer
    Phone icon
    United Kingdom
    Apr 24, 2025
  • Stylized image of a person
    R. S.
    Cfo
    Phone icon
    Norway
    Oct 08, 2024
  • Stylized image of a person
    D. M.
    Chief People Officer
    Phone icon
    NORWAYHORDALAND
    Jul 17, 2025
  • Stylized image of a person
    T. S.
    Full Time Senior Researcher, Vp Of Contract Services
    Phone icon
    Norway
    Mar 20, 2025
  • Stylized image of a person
    K. W.
    Associate Director, Global Regulatory Affairs
    Phone icon
    United Kingdom
    Nov 11, 2025
  • Stylized image of a person
    O. S.
    Director Of Financial Controlling And Business Support
    Phone icon
    Norway
    Nov 18, 2025
  • Stylized image of a person
    D. M.
    Director Of Biomarkers And Research
    Phone icon
    Norway
    Mar 20, 2025
  • Stylized image of a person
    C. B. D.
    Finance Director
    Phone icon
    Norway
    Nov 11, 2025
  • Stylized image of a person
    A. K.
    Member Of The Nomination Committee
    Phone icon
    Norway
    Jan 29, 2026

Frequently Asked Questions

What is BerGenBio ASA - Merged with Oncoinvent ASA known for?

Minus sign iconPlus sign icon
BerGenBio ASA - Merged with Oncoinvent ASA was founded in 2008 operates in the Biotechnology Research industry. The company's main headquarters is located in 91 Jonas Lies Vei Bergen, Vestland 5009 Norway; you can contact the main corporate office by phone at . Explore BerGenBio ASA - Merged with Oncoinvent ASA's company overview page for more information.

What is BerGenBio ASA - Merged with Oncoinvent ASA's most common email format?

Minus sign iconPlus sign icon
BerGenBio ASA - Merged with Oncoinvent ASA employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more BerGenBio ASA - Merged with Oncoinvent ASA email formats with LeadIQ.

How many employees does BerGenBio ASA - Merged with Oncoinvent ASA have currently?

Minus sign iconPlus sign icon
BerGenBio ASA - Merged with Oncoinvent ASA has approximately 8 employees as of February 2026. These team members are located across 1 continents, including Europe.

Who are BerGenBio ASA - Merged with Oncoinvent ASA's key employees and leadership?

Minus sign iconPlus sign icon

As of February 2026, BerGenBio ASA - Merged with Oncoinvent ASA's key employees include:

  • Chief Executive Officer: O. H.
  • Cfo: R. S.
  • Chief People Officer: D. M.
  • Full Time Senior Researcher, Vp Of Contract Services: T. S.
  • Associate Director, Global Regulatory Affairs: K. W.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.